The landscape of medical treatments is rapidly transforming. Monoclonal antibodies, a pivotal class in biologics, have been at the forefront since their inception in 1986.
Author: Hannah Everett
Hannah Everett is a seasoned technology writer with a focus on the evolving landscape of fintech and emerging technologies. She holds a Bachelor’s degree in Business Administration from the prestigious University of Southern California, where her passion for innovation and finance took root. With over a decade of experience in the tech industry, Hannah has honed her expertise while working at Converge Solutions, a leading firm specializing in digital financial services. Her insightful analyses and forward-thinking articles have been featured in various esteemed publications, where she explores the intersection of technology and finance, providing readers with a nuanced understanding of the future of money. Through her work, Hannah aims to bridge the gap between complex technological concepts and practical applications in the financial sector.